IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Emcure Pharmaceuticals Limited is an Pharmaceutical based company, located in Pune, Emcure Pharmaceuticals Limited IPO size was 1952.03 Cr. and was issued at 1008.00 per share. The share of Emcure Pharmaceuticals Limited were listed at 1358.85 per share and are currently trading at 1098.80 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Emcure Pharmaceuticals operates in Pharmaceutical and Broad Range Of Pharma. The Issue is listed on BSE,NSE in Jul, 2024. Emcure Pharmaceuticals IPO size was 1952.03 Cr. with Issue price of 1008.00 .
Merchant Banker(s) of Emcure Pharmaceuticals IPO: Axis Capital Limited , J.P. Morgan India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Emcure Pharmaceuticals IPO subscription was 67.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Emcure Pharmaceuticals IPO listed at a listing price of 1358.85 against the offer price of 1008.00.
The current market price of Emcure Pharmaceuticals is 1098.80.
Why Us?
